Risultati ricerca pubblicazioni

Infliximab is not associated with increased risk of malignancy or hemophagocytic lymphohistiocytosis in pediatric patients with inflammatory bowel disease

pubblicato su: GASTROENTEROLOGY - 2017

Hyams Jeffrey S., Dubinsky Marla C., Baldassano Robert N., Colletti Richard B., Cucchiara Salvatore, Escher Johanna, Faubion William, Fell John, Gold Benjamin D., Griffiths Anne, Koletzko Sibylle, Kugathasan Subra, Markowitz James, Ruemmele Frank M., Veereman Gigi, Winter Harland, Masel Nicholas, Shin Chu Ri, Tang Kezhen L., Thayu Meena